SI3564357T1 - Bakterioterapija Clostridium Difficile colitisa - Google Patents
Bakterioterapija Clostridium Difficile colitisaInfo
- Publication number
- SI3564357T1 SI3564357T1 SI201132058T SI201132058T SI3564357T1 SI 3564357 T1 SI3564357 T1 SI 3564357T1 SI 201132058 T SI201132058 T SI 201132058T SI 201132058 T SI201132058 T SI 201132058T SI 3564357 T1 SI3564357 T1 SI 3564357T1
- Authority
- SI
- Slovenia
- Prior art keywords
- bacteriotherapy
- clostridium difficile
- difficile colitis
- colitis
- clostridium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33728310P | 2010-02-01 | 2010-02-01 | |
| US35118410P | 2010-06-03 | 2010-06-03 | |
| EP19176151.9A EP3564357B1 (en) | 2010-02-01 | 2011-02-01 | Bacteriotherapy for clostridium difficile colitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3564357T1 true SI3564357T1 (sl) | 2022-09-30 |
Family
ID=44319684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201132058T SI3564357T1 (sl) | 2010-02-01 | 2011-02-01 | Bakterioterapija Clostridium Difficile colitisa |
Country Status (14)
| Country | Link |
|---|---|
| US (7) | US9629881B2 (sl) |
| EP (4) | EP3564357B1 (sl) |
| AU (1) | AU2011209940B2 (sl) |
| CA (1) | CA2788558C (sl) |
| DK (1) | DK3564357T3 (sl) |
| ES (3) | ES2916399T3 (sl) |
| HR (1) | HRP20220751T1 (sl) |
| HU (1) | HUE059169T2 (sl) |
| LT (1) | LT3564357T (sl) |
| PL (1) | PL3564357T3 (sl) |
| PT (1) | PT3564357T (sl) |
| RS (1) | RS63299B1 (sl) |
| SI (1) | SI3564357T1 (sl) |
| WO (1) | WO2011094027A1 (sl) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| SI3564357T1 (sl) | 2010-02-01 | 2022-09-30 | Rebiotix, Inc. | Bakterioterapija Clostridium Difficile colitisa |
| JP2013537531A (ja) | 2010-08-04 | 2013-10-03 | トーマス・ジュリアス・ボロディ | 糞便細菌叢移植のための組成物ならびにそれを作製および使用する方法ならびにそれを送達するためのデバイス |
| AU2012225305B2 (en) * | 2011-03-09 | 2017-06-08 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| US9176026B2 (en) | 2011-12-15 | 2015-11-03 | Pureflora, Inc. | Device for the collection, refinement, and administration of gastrointestinal microflora |
| EP2850202B1 (en) * | 2012-05-18 | 2020-03-11 | Genome Research Limited | Methods and groups |
| WO2013176774A1 (en) | 2012-05-25 | 2013-11-28 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| JP2016509003A (ja) | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
| WO2014121304A1 (en) | 2013-02-04 | 2014-08-07 | Seres Health, Inc. | Compositions and methods |
| JP2016519664A (ja) | 2013-03-15 | 2016-07-07 | セレス セラピューティクス インコーポレイテッド | ネットワークを基にした微生物組成物及び方法 |
| US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US9511099B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US9511100B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| PL3003330T3 (pl) | 2013-06-05 | 2019-03-29 | Rebiotix, Inc. | Terapia przywracająca mikrobiota (MRT), kompozycje i sposoby wytwarzania |
| KR102515850B1 (ko) | 2013-11-25 | 2023-03-30 | 세레스 테라퓨틱스, 인코포레이티드 | 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도 |
| US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| AU2016259871B2 (en) | 2015-05-11 | 2020-04-16 | Mybiotics Pharma Ltd | Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut |
| KR102561989B1 (ko) | 2015-05-14 | 2023-07-31 | 핀치 테라퓨틱스 홀딩스 엘엘씨 | 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치 |
| CN108243608A (zh) | 2015-05-22 | 2018-07-03 | 亚利桑那大学董事会 | 用于治疗自闭症谱系障碍及相关症状的方法 |
| US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| PL3307289T3 (pl) | 2015-06-09 | 2022-01-17 | Rebiotix, Inc. | Sposoby wytwarzania kompozycji do terapii przywracającej mikrobiotę (mrt) |
| US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| SG11201810428PA (en) | 2016-05-25 | 2018-12-28 | Mybiotics Pharma Ltd | Composition and methods for microbiota therapy |
| US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
| US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
| US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
| US11959125B2 (en) | 2016-09-15 | 2024-04-16 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| KR102530297B1 (ko) | 2016-09-27 | 2023-05-10 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 미생물유전체를 조정함으로써 면역 체크포인트 차단 요법을 증강시키는 방법 |
| US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| US11213549B2 (en) | 2016-10-11 | 2022-01-04 | Finch Therapeutics Holdings Llc | Compositions and method for treating primary sclerosing cholangitis and related disorders |
| US11026978B2 (en) | 2016-10-11 | 2021-06-08 | Finch Therapeutics Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| CA3058943C (en) | 2017-04-03 | 2023-10-17 | Gusto Global, Llc | Rational design of microbial-based biotherapeutics |
| US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
| EP3606541A1 (en) | 2017-04-05 | 2020-02-12 | Crestovo Holdings LLC | Compositions and methods for treating parkinson's disease (pd) and related disorders |
| CA3064773A1 (en) | 2017-05-26 | 2018-11-29 | Crestovo Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
| CN111328284A (zh) | 2017-08-07 | 2020-06-23 | 芬奇治疗公司 | 用于维持和恢复健康的肠道屏障的组合物和方法 |
| AU2018318132A1 (en) | 2017-08-14 | 2020-02-27 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
| AU2018347619A1 (en) | 2017-10-13 | 2020-04-09 | Rebiotix, Inc. | Microbiome health index |
| WO2019213595A1 (en) | 2018-05-04 | 2019-11-07 | Ferring B.V. | Microbiota restoration therapy (mrt) compositions and methods of manufacture |
| WO2019241523A1 (en) | 2018-06-14 | 2019-12-19 | Rebiotix, Inc. | Microbiota restoration therapy (mrt) compositions and methods of manufacture |
| US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
| CN112888447A (zh) * | 2018-08-17 | 2021-06-01 | 韦丹塔生物科学股份有限公司 | 减少菌群失调和恢复微生物群系的方法 |
| AU2019351017A1 (en) | 2018-09-27 | 2021-04-29 | Finch Therapeutics Holdings Llc. | Compositions and methods for treating epilepsy and related disorders |
| CN113905749A (zh) * | 2019-01-16 | 2022-01-07 | 德克萨斯大学系统董事会 | 用于治疗免疫检查点抑制剂相关结肠炎的方法和组合物 |
| WO2021096794A1 (en) * | 2019-11-11 | 2021-05-20 | Hazan Sabine | Method of treating an individual with a health condition with fecal microbiota transplant |
| US11744866B2 (en) | 2020-03-18 | 2023-09-05 | Sabine Hazan | Methods of preventing and treating COVID-19 infection with probiotics |
| KR20230018389A (ko) | 2020-06-01 | 2023-02-07 | 훼링 비.브이. | 질 미생물총 조성물 |
| WO2022051610A1 (en) | 2020-09-04 | 2022-03-10 | Ferring B.V. | Microbiota restoration therapy (mrt) compositions and methods of manufacture |
| WO2023150544A1 (en) * | 2022-02-01 | 2023-08-10 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Simplified method of preparing cells for patient administration |
Family Cites Families (120)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL257275A (sl) | 1959-10-26 | |||
| US3261761A (en) | 1962-05-07 | 1966-07-19 | Arthur W Anderson | Method of freeze drying bacterial cultures |
| JP2733849B2 (ja) | 1987-10-12 | 1998-03-30 | ボロディー，ソーマス・ユリウス | 胃腸障害治療のための改良された方法 |
| AU2900889A (en) | 1987-12-24 | 1989-07-19 | Thomas Julius Borody | Orthostatic lavage solutions |
| US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
| ATE165738T1 (de) | 1988-08-02 | 1998-05-15 | Gastro Services Pty Ltd | Behandlung von gastro-intestinalen krankheiten |
| CA1337265C (en) | 1988-08-04 | 1995-10-10 | Thomas Julius Borody | Oral antibody therapy for patients with lowered immune response and composition therefor |
| CA2051092C (en) | 1990-09-12 | 2002-07-23 | Stephen A. Livesey | Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions |
| CA2090220C (en) | 1990-10-22 | 2003-07-08 | Thomas Julius Borody | Treatment of non-inflammatory and non-infectious bowel disorders |
| US5519014A (en) | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
| US5229374A (en) | 1992-01-28 | 1993-07-20 | Burton Albert F | Method for treatment of lower gastrointestinal tract disorders |
| US5599795A (en) | 1994-08-19 | 1997-02-04 | Mccann; Michael | Method for treatment of idiopathic inflammatory bowel disease (IIBD) |
| AUPM864894A0 (en) | 1994-10-07 | 1994-11-03 | Borody, Thomas Julius | Treatment of bowel-dependent neurological disorders |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US5656283A (en) | 1995-06-08 | 1997-08-12 | Ortho Pharmaceutical Corporation | In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product |
| DE69635496T2 (de) | 1995-09-15 | 2006-07-27 | Gerding, Dale N., Chicago | Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen |
| AUPN634595A0 (en) | 1995-11-03 | 1995-11-30 | Borody, Thomas Julius | Improved method for colonic evacuation |
| US6103268A (en) | 1995-11-03 | 2000-08-15 | Borody; Thomas Julius | Administering osmotic colonic evacuant containing a picosulfate |
| US5925354A (en) | 1995-11-30 | 1999-07-20 | Michigan State University | Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
| US5711446A (en) * | 1996-01-16 | 1998-01-27 | Sorenson Bioscience, Inc. | Cryogenic freezing vial |
| US5902578A (en) | 1996-03-25 | 1999-05-11 | Abbott Laboratories | Method and formula for the prevention of diarrhea |
| US5837238A (en) | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
| US6096310A (en) | 1997-04-15 | 2000-08-01 | Bier; Milan | Oral immunotherapy of bacterial overgrowth |
| AUPO665397A0 (en) | 1997-05-07 | 1997-05-29 | Borody, Thomas Julius | Novel therapy for constipation |
| US6969520B2 (en) | 1997-10-20 | 2005-11-29 | Acambis Inc. | Active immunization against clostridium difficile disease |
| EP2305293A3 (en) | 1997-10-20 | 2013-11-06 | Sanofi Pasteur Biologics Co. | Immunization against Clostridium difficile disease |
| US6428783B1 (en) | 1998-03-11 | 2002-08-06 | Medtech Center, Inc. | Bank of autochthonous strains of microorganisms and methods of its use for recovery of intestinal microbiocenosis of the men |
| US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| WO2000016619A1 (en) | 1998-09-21 | 2000-03-30 | 21St Century Medicine, Inc. | Polyvinyl alcohol compounds for inhibition of ice growth |
| ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| US7430478B2 (en) * | 2000-03-01 | 2008-09-30 | Caridian Bct, Inc. | Blood processing information system with blood loss equivalency tracking |
| FR2808689B1 (fr) | 2000-05-11 | 2004-09-03 | Agronomique Inst Nat Rech | Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs |
| US20040170617A1 (en) * | 2000-06-05 | 2004-09-02 | Finegold Sydney M. | Method of treating diseases associated with abnormal gastrointestinal flora |
| US20020013270A1 (en) | 2000-06-05 | 2002-01-31 | Bolte Ellen R. | Method for treating a mental disorder |
| US20040062757A1 (en) | 2001-06-05 | 2004-04-01 | Finegold Sydney M. | Method of testing gastrointestinal diseases associated with species of genus clostridium |
| WO2001097821A1 (en) | 2000-06-19 | 2001-12-27 | Mucoprotec Pty Ltd | Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor. |
| EP1303285A2 (en) | 2000-07-17 | 2003-04-23 | Chr. Hansen A/S | Methods and formulations with probiotic microorganisms and medicaments |
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| EP2071332A1 (en) | 2000-11-14 | 2009-06-17 | Techlab, Inc. | Method for monitoring persons with IBD using total endogeneous lactoferrin as a marker |
| SG173211A1 (en) | 2001-06-26 | 2011-08-29 | Amgen Inc | Antibodies to opgl |
| CN100354429C (zh) | 2001-09-06 | 2007-12-12 | 基因描绘系统有限公司 | 一种检测样品中靶分子的方法 |
| EP1300472A1 (en) | 2001-10-02 | 2003-04-09 | Stichting Top-Instituut Voedselwetenschappen | A method for testing the effect of nutrients on gastrointestinal colonisation resistance of humans |
| GB0124580D0 (en) | 2001-10-12 | 2001-12-05 | Univ Reading | New composition |
| EP1448987A4 (en) * | 2001-12-10 | 2005-06-08 | Ardais Corp | SYSTEM AND METHODS FOR OBTAINING PATIENT SAMPLES IN CORRELATION WITH DATA |
| US20030161871A1 (en) | 2001-12-19 | 2003-08-28 | Geoffrey Hird | Solubilized riboflavin |
| AUPS088702A0 (en) | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| US20040265291A1 (en) | 2003-01-24 | 2004-12-30 | Flora Technology Inc. | Compositions and methods for restoring bacterial flora |
| GB0322791D0 (en) | 2003-09-30 | 2003-10-29 | Lifeforce Group Plc | Blood co-processing for contingent autologous leukocyte transplantation |
| US20050239706A1 (en) | 2003-10-31 | 2005-10-27 | Washington University In St. Louis | Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject |
| US20060008511A1 (en) | 2004-07-08 | 2006-01-12 | Jhy-Jhu Lin | Probiotic products for pet applications |
| US7935334B2 (en) | 2005-07-07 | 2011-05-03 | Imagilin Technologies, LLC | Probiotics as alternative medicines against infectious diseases |
| US7909806B2 (en) | 2004-09-23 | 2011-03-22 | Anthrogenesis Corporation | Cord blood and placenta collection kit |
| CA2582137A1 (en) | 2004-10-05 | 2007-02-15 | Wyeth | Probe arrays for detecting multiple strains of different species |
| EP1828953B1 (en) | 2004-11-08 | 2013-03-06 | Yale University Corporation | Crystalline xpt guanine riboswitch from Bacillus subtilis and structure-based compound identification employing said riboswitch |
| US20060210448A1 (en) | 2005-03-10 | 2006-09-21 | Naishu Wang | Fecal specimen collection, preserving and transport device and method |
| ES2526415T3 (es) | 2005-03-17 | 2015-01-12 | Synthon B.V. | Comprimidos farmacéuticos de aripiprazol cristalino de tipo II |
| US7607776B1 (en) | 2005-10-24 | 2009-10-27 | James Waller Lambuth Lewis | Digital eye bank for virtual clinic trials |
| EP1974052A2 (en) | 2005-12-21 | 2008-10-01 | Yale University | Methods and compositions related to the modulation of riboswitches |
| JP2009522311A (ja) | 2005-12-29 | 2009-06-11 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 動物における腸内細菌叢を調節する方法 |
| US20080027353A1 (en) | 2006-07-31 | 2008-01-31 | Kliman Harvey J | Method of making and using a library of biological information |
| RU2009117828A (ru) | 2006-10-13 | 2010-11-20 | Релайанс Лайф Сайенсиз Пвт. Лтд. (In) | Культивированные меланоциты на биополимерах |
| EP2102350A4 (en) | 2006-12-18 | 2012-08-08 | Univ St Louis | INTESTINAL MICROBIOMA AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR OBESITY-RELATED DISORDER |
| WO2009029315A2 (en) | 2007-05-31 | 2009-03-05 | University Of Washington | Inducible mutagenesis of target genes |
| EP2030623A1 (en) | 2007-08-17 | 2009-03-04 | Nestec S.A. | Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
| WO2009042645A2 (en) | 2007-09-24 | 2009-04-02 | President And Fellows Of Harvard College | The use of mice predisposed to develop ulcerative colitis and colon cancer to develop metabolic profiles associated with same |
| US20090138354A1 (en) | 2007-11-25 | 2009-05-28 | Herbert Zech | Methods of Storing and Providing Samples of Cells and Tissue |
| US20090148540A1 (en) | 2007-12-10 | 2009-06-11 | Mi Hope Incorporated | Antibacterial composition and method of production |
| WO2009120347A2 (en) | 2008-03-27 | 2009-10-01 | Memorial Sloan Kettering Cancer Center | Modulators of rna riboswitches |
| WO2010002890A2 (en) | 2008-06-30 | 2010-01-07 | The Washington University | Methods of promoting weight loss and associated arrays |
| US20100008850A1 (en) | 2008-07-14 | 2010-01-14 | William John Martin | Method of generating hydrogen in drinking water using an enerceutical product added to magnesium in a hydrogen permeable but solute impermeable container |
| CA2729244C (en) | 2008-07-17 | 2018-03-27 | Bioworks, Inc. | Control of plant diseases and enhancing plant growth using a combination of a trichoderma virens species and a rhizosphere competent trichoderma harzianum species |
| KR20110097754A (ko) | 2008-08-11 | 2011-08-31 | 바이오렐릭스, 인크. | 플라빈 유도체 |
| NZ595767A (en) | 2009-05-01 | 2012-12-21 | Ferring Bv | Composition for the treatment of prostate cancer |
| GB0916335D0 (en) | 2009-09-17 | 2009-10-28 | Martin W J | Medicaments |
| WO2011036539A1 (en) | 2009-09-23 | 2011-03-31 | Borody Thomas J | Therapy for enteric infections |
| CA2778182C (en) | 2009-10-22 | 2018-04-17 | Thomas Julius Borody | Novel parasite therapy |
| US8772242B2 (en) | 2009-10-26 | 2014-07-08 | Thomas Julius Borody | Therapy for enteric infections |
| SI3564357T1 (sl) | 2010-02-01 | 2022-09-30 | Rebiotix, Inc. | Bakterioterapija Clostridium Difficile colitisa |
| US8853269B2 (en) | 2010-02-04 | 2014-10-07 | Copperhead Chemical Company Inc. | Composition and method for treating infections and promoting intestinal health |
| FI20105478A0 (fi) | 2010-04-30 | 2010-04-30 | Valtion Teknillinen | Menetelmä tyypin 1 diabeteksen diagnosoimiseksi ja menetelmiä ja koostumuksia tyypin 1 diabeteksen puhkeamisen estämiseksi |
| US9707207B2 (en) | 2010-05-26 | 2017-07-18 | The United States Of America As Represented By The Department Of Veterans Affairs | Method for diagnosing, preventing, and treating neurological diseases |
| WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 |
| WO2012013861A2 (en) | 2010-07-26 | 2012-02-02 | Suomen Punainen Risti Veripalvelu | Use of blood group status iii |
| FI20105825A (fi) | 2010-07-26 | 2012-01-27 | Suomen Punainen Risti Veripalvelu | Veriryhmästatuksen käyttö III |
| JP2013537531A (ja) | 2010-08-04 | 2013-10-03 | トーマス・ジュリアス・ボロディ | 糞便細菌叢移植のための組成物ならびにそれを作製および使用する方法ならびにそれを送達するためのデバイス |
| US9386793B2 (en) | 2010-08-20 | 2016-07-12 | New York University | Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota |
| WO2012033814A2 (en) | 2010-09-10 | 2012-03-15 | Viropharma Incorporated | Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use |
| WO2014152484A1 (en) | 2013-03-14 | 2014-09-25 | Regents Of The University Of Minnesota | Freeze dried fecal microbiota for use in fecal microbial transplantation |
| AU2012225305B2 (en) | 2011-03-09 | 2017-06-08 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| WO2012122522A2 (en) | 2011-03-09 | 2012-09-13 | Washington University | Cultured collection of gut microbial community |
| WO2012142605A1 (en) | 2011-04-15 | 2012-10-18 | Samaritan Health Services | Rapid recolonization deployment agent |
| US20120276060A1 (en) | 2011-04-29 | 2012-11-01 | Techlab, Inc. | Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with clostridium difficile disease |
| US20130022575A1 (en) | 2011-07-19 | 2013-01-24 | Microbial Rx | Systems and methods of replacing intestinal flora |
| JP2014525266A (ja) | 2011-08-26 | 2014-09-29 | マイクロバイオータ ダイアグノスティクス， エルエルシー | 心欠陥を診断および治療する方法 |
| KR20140082964A (ko) | 2011-10-11 | 2014-07-03 | 아힘 바이오테라퓨틱스 에이비 | 혐기성 조건으로 배양된 인간 장내 미생물을 포함하는 조성물 |
| US9176026B2 (en) | 2011-12-15 | 2015-11-03 | Pureflora, Inc. | Device for the collection, refinement, and administration of gastrointestinal microflora |
| IN2014DN07752A (sl) | 2012-02-29 | 2015-05-15 | Ethicon Endo Surgery Inc | |
| EP2636684A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Prevention of infection |
| US9421233B2 (en) | 2012-04-27 | 2016-08-23 | Cedars-Sinai Medical Center | Fungal mycobiome as probiotics, diagnostics and therapeutics |
| EP2850202B1 (en) | 2012-05-18 | 2020-03-11 | Genome Research Limited | Methods and groups |
| US20140112985A1 (en) | 2012-10-22 | 2014-04-24 | Polonez Therapeutics Llc | Method of prevention and treatment of clostridium difficile infection |
| WO2014100826A1 (en) | 2012-12-23 | 2014-06-26 | Illuminate Consulting, Llc. | Method and apparatus for thermally protecting and/or transporting temperature sensitive products |
| JP2016509003A (ja) | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
| US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US9511099B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US9511100B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| PL3003330T3 (pl) | 2013-06-05 | 2019-03-29 | Rebiotix, Inc. | Terapia przywracająca mikrobiota (MRT), kompozycje i sposoby wytwarzania |
| US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| KR102561989B1 (ko) | 2015-05-14 | 2023-07-31 | 핀치 테라퓨틱스 홀딩스 엘엘씨 | 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치 |
| CN108243608A (zh) | 2015-05-22 | 2018-07-03 | 亚利桑那大学董事会 | 用于治疗自闭症谱系障碍及相关症状的方法 |
| WO2016196605A1 (en) | 2015-06-01 | 2016-12-08 | The University Of Chicago | Treatment of cancer by manipulation of commensal microflora |
| PL3307289T3 (pl) | 2015-06-09 | 2022-01-17 | Rebiotix, Inc. | Sposoby wytwarzania kompozycji do terapii przywracającej mikrobiotę (mrt) |
| US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| US10173160B2 (en) | 2015-10-09 | 2019-01-08 | Heinzen, Llc | Effluent removal system and method of use |
| ITUB20169847A1 (it) | 2016-01-05 | 2017-07-05 | Wellmicro S R L | Metodo per valutare lo stato di salute di un individuo |
| US20180000872A1 (en) | 2016-07-01 | 2018-01-04 | Regents Of The University Of Minnesota | Compositions and methods for c. difficile treatment |
-
2011
- 2011-02-01 SI SI201132058T patent/SI3564357T1/sl unknown
- 2011-02-01 PL PL19176151.9T patent/PL3564357T3/pl unknown
- 2011-02-01 ES ES19176151T patent/ES2916399T3/es active Active
- 2011-02-01 EP EP19176151.9A patent/EP3564357B1/en active Active
- 2011-02-01 AU AU2011209940A patent/AU2011209940B2/en active Active
- 2011-02-01 ES ES11737418.1T patent/ES2623127T3/es active Active
- 2011-02-01 ES ES17155133T patent/ES2730828T3/es active Active
- 2011-02-01 EP EP22160187.5A patent/EP4032586A1/en active Pending
- 2011-02-01 HR HRP20220751TT patent/HRP20220751T1/hr unknown
- 2011-02-01 PT PT191761519T patent/PT3564357T/pt unknown
- 2011-02-01 LT LTEP19176151.9T patent/LT3564357T/lt unknown
- 2011-02-01 HU HUE19176151A patent/HUE059169T2/hu unknown
- 2011-02-01 DK DK19176151.9T patent/DK3564357T3/da active
- 2011-02-01 EP EP17155133.6A patent/EP3181684B1/en active Active
- 2011-02-01 WO PCT/US2011/000184 patent/WO2011094027A1/en active Application Filing
- 2011-02-01 EP EP11737418.1A patent/EP2531589B1/en active Active
- 2011-02-01 US US13/576,573 patent/US9629881B2/en active Active
- 2011-02-01 CA CA2788558A patent/CA2788558C/en active Active
- 2011-02-01 RS RS20220556A patent/RS63299B1/sr unknown
-
2013
- 2013-12-02 US US14/093,913 patent/US9463208B2/en active Active
-
2016
- 2016-08-30 US US15/251,725 patent/US20160367607A1/en not_active Abandoned
-
2017
- 2017-06-02 US US15/612,505 patent/US20170266241A1/en not_active Abandoned
-
2018
- 2018-04-27 US US15/964,228 patent/US11446337B2/en active Active
-
2022
- 2022-08-11 US US17/886,274 patent/US11944654B2/en active Active
-
2023
- 2023-12-18 US US18/544,083 patent/US20240122995A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2531589A4 (en) | BACTERIENT THERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS | |
| GB2498008B (en) | State transition | |
| GB2506331B (en) | Seal member | |
| HK1199886A1 (en) | Clostridium difficile antibodies | |
| DK3327110T3 (en) | Kassette til sterilitetstest | |
| DK2737264T3 (en) | Startlogik til kølesystem | |
| GB201016742D0 (en) | Clostridium difficile antigens | |
| HK1189301A1 (zh) | 開關裝置 | |
| ZA201409097B (en) | Solid state bioreactor adapted for automation | |
| HK1202805A1 (en) | Clostridium difficile antigens | |
| GB2495092B (en) | Sealing arrangement | |
| IL232957A0 (en) | A composition based on clostridium difficile toxin | |
| HK1216999A1 (zh) | 針對艱難梭菌的抗體 | |
| IL237172A0 (en) | פוליפפטידים של clostridium difficile כתרכיבים | |
| EP2548959A4 (en) | FLORIGENIC ACTIVATOR COMPLEX | |
| GB201105625D0 (en) | Seal | |
| ZA201403228B (en) | Heterocyclypyri(mi)dinylpyrazole | |
| EP2765177A4 (en) | GASIFICATION SYSTEM | |
| GB201120213D0 (en) | B0-U component seal | |
| GB201107459D0 (en) | Seal | |
| ZA201402298B (en) | Heterocyclylpyri (mi)dinylpyrazole as fungicidals | |
| EP2780351A4 (en) | LIPOTHEICHOIC ACID OF DIFFICULT CLOSTRIDIUM AND USES THEREOF | |
| GB2500854B (en) | Biosurface engineering | |
| PL2495467T3 (pl) | System uszczelniający | |
| HK1195874A1 (zh) | 艱難梭狀芽孢杆菌增殖抑制劑 |